人工唾液市場：製品形態、エンドユーザー、流通チャネル別-2025～2030年の世界予測

人工唾液市場は、2023年に9億2,377万米ドルと評価され、2024年には9億8,052万米ドルに達すると予測され、CAGR 6.33%で成長し、2030年には14億2,006万米ドルに達すると予測されています。

人工唾液は、天然の唾液の潤滑機能を模倣するように設計された製品であり、主に口腔乾燥症として知られるドライマウス状態の治療に使用されます。口腔乾燥症は、薬剤の副作用、放射線療法、自己免疫疾患、加齢など様々な原因によって引き起こされます。人工唾液の必要性は、ドライマウスに関連する症状を緩和する役割にあります。ドライマウスを治療しないと、会話や食事が困難になったり、虫歯が増えたり、口腔感染症になったりする可能性があります。

人工唾液の応用範囲は広く、主に医療産業、特に高齢者医療、腫瘍学、特定の薬理学的治療を受けている患者を対象としています。その最終用途範囲は、長期の口腔乾燥症管理を必要とする個々の患者や、患者のケアプランに組み込む医療施設からなります。人工唾液市場の主要成長要因としては、人口の高齢化、がん治療の増加、口腔乾燥がQOLに与える影響に対する認識の高まりなどが挙げられます。さらに、口腔衛生に対する意識の高まりも市場拡大に大きく寄与しています。

この市場の新たな開拓機会は、治療上の利点を付加した人工唾液の開発や、保湿性を高める新しい製剤の使用など、製品のイノベーションにあります。さらに、高齢者の多い新興市場を特定し、そこに進出することで、かなりの成長の可能性が期待できます。しかし、この市場における課題としては、製品の有効性に関する懸念、高コスト、規制当局の承認プロセス、洗口液やトローチのような代替治療との競合などが挙げられます。

技術革新と研究が必要なセグメントとしては、より効果的な送達メカニズムの開発、自然の唾液をより忠実に模倣するためのプロバイオティクスと酵素の統合、ニッチな層に対応するための個別化製剤などがあります。全体として、人工唾液市場の性質はダイナミックであり、より優れた有効性と患者のコンプライアンスを追求する継続的な研究開発活動が特徴です。市場浸透のためには、企業は口腔乾燥症と人工唾液製品の利点に関する認知度を高めるための教育キャンペーンに力を入れるべきであり、同時にユーザーエクスペリエンスを向上させるための革新的で費用対効果の高いソリューションの強力なパイプラインを維持する必要があります。

市場力学：急速に進化する人工唾液市場の主要市場洞察を公開

人工唾液市場は、需要と供給のダイナミックな相互作用によって変貌を遂げています。このような市場力学の進化を理解することで、企業は十分な情報に基づいた投資決定、戦略的決定の精緻化、そして新たなビジネス機会の獲得に備えることができます。これらの動向を包括的に把握することで、企業は政治的、地理的、技術的、社会的、経済的な領域にわたる様々なリスクを軽減することができ、また、消費者行動とそれが製造コストや購買動向に与える影響をより明確に理解することができます。

• 市場促進要因
  • ドライマウス症状の増加
  • がんの流行と化学療法の急増
  • 世界の歯科疾患の増加
• 市場抑制要因
  • 人工唾液の有効性に関する懸念
• 市場機会
  • 人工唾液製剤の革新
  • 人工唾液を製造するための戦略的提携と共同研究
• 市場課題
  • 複雑な薬事承認手続き

ポーターのファイブフォース：人工唾液市場をナビゲートする戦略ツール

ポーターのファイブフォースフレームワークは、人工唾液市場の競合情勢を理解するための重要なツールです。ポーターのファイブフォースフレームワークは、企業の競合を評価し、戦略的機会を探るための明確な手法を記載しています。このフレームワークは、企業が市場内の勢力図を評価し、新規事業の収益性を判断するのに役立ちます。これら洞察により、企業は自社の強みを活かし、弱みに対処し、潜在的な課題を回避することができ、より強靭な市場でのポジショニングを確保することができます。

PESTLE分析：人工唾液市場における外部からの影響の把握

外部マクロ環境要因は、人工唾液市場の業績力学を形成する上で極めて重要な役割を果たします。政治的、経済的、社会的、技術的、法的、環境的要因の分析は、これらの影響をナビゲートするために必要な情報を記載しています。PESTLE要因を調査することで、企業は潜在的なリスクと機会をよりよく理解することができます。この分析により、企業は規制、消費者の嗜好、経済動向の変化を予測し、先を見越した積極的な意思決定を行う準備ができます。

市場シェア分析：人工唾液市場における競合情勢の把握

人工唾液市場の詳細な市場シェア分析により、ベンダーの業績を包括的に評価することができます。企業は、収益、顧客ベース、成長率などの主要指標を比較することで、競争上のポジショニングを明らかにすることができます。この分析により、市場の集中、セグメント化、統合の動向が明らかになり、ベンダーは競争が激化する中で自社の地位を高める戦略的意思決定を行うために必要な知見を得ることができます。

FPNVポジショニングマトリックス：人工唾液市場におけるベンダーのパフォーマンス評価

FPNVポジショニングマトリックスは、人工唾液市場においてベンダーを評価するための重要なツールです。このマトリックスにより、ビジネス組織はベンダーのビジネス戦略と製品満足度に基づき評価することで、目標に沿った十分な情報に基づいた意思決定を行うことができます。4つの象限によってベンダーを明確かつ正確にセグメント化し、戦略目標に最適なパートナーやソリューションを特定することができます。

戦略分析と推奨：人工唾液市場における成功への道筋を描く

人工唾液市場の戦略分析は、世界市場でのプレゼンス強化を目指す企業にとって不可欠です。主要なリソース、能力、業績指標を見直すことで、企業は成長機会を特定し、改善に取り組むことができます。このアプローチにより、競合情勢における課題を克服し、新たなビジネス機会を活かして長期的な成功を収めるための体制を整えることができます。

本レポートでは、主要な注目セグメントを網羅した市場の包括的な分析を提供しています。

1.市場の浸透度：現在の市場環境の詳細なレビュー、主要企業による広範なデータ、市場でのリーチと全体的な影響力を評価します。

2.市場の開拓度：新興市場における成長機会を特定し、既存セグメントにおける拡大可能性を評価し、将来の成長に向けた戦略的ロードマップを記載しています。

3.市場の多様化：最近の製品発売、未開拓の地域、産業の主要な進歩、市場を形成する戦略的投資を分析します。

4.競合の評価と情報：競合情勢を徹底的に分析し、市場シェア、事業戦略、製品ポートフォリオ、認証、規制当局の承認、特許動向、主要企業の技術進歩などを検証します。

5.製品開発とイノベーション：将来の市場成長を促進すると期待される最先端技術、研究開発活動、製品イノベーションをハイライトしています。

また、利害関係者が十分な情報を得た上で意思決定できるよう、重要な質問にも答えています。

1.現在の市場規模と今後の成長予測は？

2.最高の投資機会を提供する製品、地域はどこか？

3.市場を形成する主要技術動向と規制の影響とは？

4.主要ベンダーの市場シェアと競合ポジションは？

5.ベンダーの市場参入・撤退戦略の原動力となる収益源と戦略的機会は何か？

目次

第1章 序文

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 市場概要

第5章 市場洞察

• 市場力学
  • 促進要因
    • 口腔乾燥症の発生率増加
    • がんの蔓延と化学療法治療の急増
    • 世界中で歯科疾患が増加
  • 抑制要因
    • 人工唾液の有効性に関する懸念
  • 機会
    • 人工唾液配合における革新
    • 製造における戦略的提携と協力人工唾液
  • 課題
    • 複雑な規制承認手続き
• 市場セグメンテーション分析
• ポーターのファイブフォース分析
• PESTEL分析
  • 政治
  • 経済
  • 社会
  • 技術
  • 法律
  • 環境

第6章 人工唾液市場：製品形態別

• イントロダクション
• ゲル
• 液体
• 粉末
• スプレー
• 錠剤

第7章 人工唾液市場：エンドユーザー別

• イントロダクション
• 成人
• 小児

第8章 人工唾液市場：流通チャネル別

• イントロダクション
• オフライン
• オンライン

第9章 南北アメリカの人工唾液市場

• イントロダクション
• アルゼンチン
• ブラジル
• カナダ
• メキシコ
• 米国

第10章 アジア太平洋の人工唾液市場

• イントロダクション
• オーストラリア
• 中国
• インド
• インドネシア
• 日本
• マレーシア
• フィリピン
• シンガポール
• 韓国
• 台湾
• タイ
• ベトナム

第11章 欧州・中東・アフリカの人工唾液市場

• イントロダクション
• デンマーク
• エジプト
• フィンランド
• フランス
• ドイツ
• イスラエル
• イタリア
• オランダ
• ナイジェリア
• ノルウェー
• ポーランド
• カタール
• ロシア
• サウジアラビア
• 南アフリカ
• スペイン
• スウェーデン
• スイス
• トルコ
• アラブ首長国連邦
• 英国

第12章 競合情勢

• 市場シェア分析、2023年
• FPNVポジショニングマトリックス、2023年
• 競合シナリオ分析
• 戦略分析と提言

企業一覧

• Aritech Chemazone Pvt. Ltd.
• BIO COSMETICS S.L.
• CCMed Ltd.
• Forward Science
• Fresenius Kabi Ltd.
• GlaxoSmithKline PLC
• ICPA Health Products Ltd.
• Kuraray Europe GmbH
• LIVEALTH BIOPHARMA (UK) PVT. LTD.
• Merck KGaA
• NANOCHEMAZONE
• Parnell Pharmaceuticals, Inc.
• Pickering Laboratories, Inc.
• Saliwell Ltd.

LIST OF FIGURES

• FIGURE 1. ARTIFICIAL SALIVA MARKET RESEARCH PROCESS
• FIGURE 2. ARTIFICIAL SALIVA MARKET SIZE, 2023 VS 2030
• FIGURE 3. GLOBAL ARTIFICIAL SALIVA MARKET SIZE, 2018-2030 (USD MILLION)
• FIGURE 4. GLOBAL ARTIFICIAL SALIVA MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 5. GLOBAL ARTIFICIAL SALIVA MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 6. GLOBAL ARTIFICIAL SALIVA MARKET SIZE, BY PRODUCT FORM, 2023 VS 2030 (%)
• FIGURE 7. GLOBAL ARTIFICIAL SALIVA MARKET SIZE, BY PRODUCT FORM, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 8. GLOBAL ARTIFICIAL SALIVA MARKET SIZE, BY END-USER, 2023 VS 2030 (%)
• FIGURE 9. GLOBAL ARTIFICIAL SALIVA MARKET SIZE, BY END-USER, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 10. GLOBAL ARTIFICIAL SALIVA MARKET SIZE, BY DISTRIBUTION CHANNEL, 2023 VS 2030 (%)
• FIGURE 11. GLOBAL ARTIFICIAL SALIVA MARKET SIZE, BY DISTRIBUTION CHANNEL, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 12. AMERICAS ARTIFICIAL SALIVA MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 13. AMERICAS ARTIFICIAL SALIVA MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 14. UNITED STATES ARTIFICIAL SALIVA MARKET SIZE, BY STATE, 2023 VS 2030 (%)
• FIGURE 15. UNITED STATES ARTIFICIAL SALIVA MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 16. ASIA-PACIFIC ARTIFICIAL SALIVA MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 17. ASIA-PACIFIC ARTIFICIAL SALIVA MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 18. EUROPE, MIDDLE EAST & AFRICA ARTIFICIAL SALIVA MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 19. EUROPE, MIDDLE EAST & AFRICA ARTIFICIAL SALIVA MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 20. ARTIFICIAL SALIVA MARKET SHARE, BY KEY PLAYER, 2023
• FIGURE 21. ARTIFICIAL SALIVA MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

• TABLE 1. ARTIFICIAL SALIVA MARKET SEGMENTATION & COVERAGE
• TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
• TABLE 3. GLOBAL ARTIFICIAL SALIVA MARKET SIZE, 2018-2030 (USD MILLION)
• TABLE 4. GLOBAL ARTIFICIAL SALIVA MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
• TABLE 5. GLOBAL ARTIFICIAL SALIVA MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 6. ARTIFICIAL SALIVA MARKET DYNAMICS
• TABLE 7. GLOBAL ARTIFICIAL SALIVA MARKET SIZE, BY PRODUCT FORM, 2018-2030 (USD MILLION)
• TABLE 8. GLOBAL ARTIFICIAL SALIVA MARKET SIZE, BY GEL, BY REGION, 2018-2030 (USD MILLION)
• TABLE 9. GLOBAL ARTIFICIAL SALIVA MARKET SIZE, BY LIQUID, BY REGION, 2018-2030 (USD MILLION)
• TABLE 10. GLOBAL ARTIFICIAL SALIVA MARKET SIZE, BY POWDER, BY REGION, 2018-2030 (USD MILLION)
• TABLE 11. GLOBAL ARTIFICIAL SALIVA MARKET SIZE, BY SPRAY, BY REGION, 2018-2030 (USD MILLION)
• TABLE 12. GLOBAL ARTIFICIAL SALIVA MARKET SIZE, BY TABLETS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 13. GLOBAL ARTIFICIAL SALIVA MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 14. GLOBAL ARTIFICIAL SALIVA MARKET SIZE, BY ADULT, BY REGION, 2018-2030 (USD MILLION)
• TABLE 15. GLOBAL ARTIFICIAL SALIVA MARKET SIZE, BY PEDIATRIC, BY REGION, 2018-2030 (USD MILLION)
• TABLE 16. GLOBAL ARTIFICIAL SALIVA MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 17. GLOBAL ARTIFICIAL SALIVA MARKET SIZE, BY OFFLINE, BY REGION, 2018-2030 (USD MILLION)
• TABLE 18. GLOBAL ARTIFICIAL SALIVA MARKET SIZE, BY ONLINE, BY REGION, 2018-2030 (USD MILLION)
• TABLE 19. AMERICAS ARTIFICIAL SALIVA MARKET SIZE, BY PRODUCT FORM, 2018-2030 (USD MILLION)
• TABLE 20. AMERICAS ARTIFICIAL SALIVA MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 21. AMERICAS ARTIFICIAL SALIVA MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 22. AMERICAS ARTIFICIAL SALIVA MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 23. ARGENTINA ARTIFICIAL SALIVA MARKET SIZE, BY PRODUCT FORM, 2018-2030 (USD MILLION)
• TABLE 24. ARGENTINA ARTIFICIAL SALIVA MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 25. ARGENTINA ARTIFICIAL SALIVA MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 26. BRAZIL ARTIFICIAL SALIVA MARKET SIZE, BY PRODUCT FORM, 2018-2030 (USD MILLION)
• TABLE 27. BRAZIL ARTIFICIAL SALIVA MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 28. BRAZIL ARTIFICIAL SALIVA MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 29. CANADA ARTIFICIAL SALIVA MARKET SIZE, BY PRODUCT FORM, 2018-2030 (USD MILLION)
• TABLE 30. CANADA ARTIFICIAL SALIVA MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 31. CANADA ARTIFICIAL SALIVA MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 32. MEXICO ARTIFICIAL SALIVA MARKET SIZE, BY PRODUCT FORM, 2018-2030 (USD MILLION)
• TABLE 33. MEXICO ARTIFICIAL SALIVA MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 34. MEXICO ARTIFICIAL SALIVA MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 35. UNITED STATES ARTIFICIAL SALIVA MARKET SIZE, BY PRODUCT FORM, 2018-2030 (USD MILLION)
• TABLE 36. UNITED STATES ARTIFICIAL SALIVA MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 37. UNITED STATES ARTIFICIAL SALIVA MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 38. UNITED STATES ARTIFICIAL SALIVA MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
• TABLE 39. ASIA-PACIFIC ARTIFICIAL SALIVA MARKET SIZE, BY PRODUCT FORM, 2018-2030 (USD MILLION)
• TABLE 40. ASIA-PACIFIC ARTIFICIAL SALIVA MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 41. ASIA-PACIFIC ARTIFICIAL SALIVA MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 42. ASIA-PACIFIC ARTIFICIAL SALIVA MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 43. AUSTRALIA ARTIFICIAL SALIVA MARKET SIZE, BY PRODUCT FORM, 2018-2030 (USD MILLION)
• TABLE 44. AUSTRALIA ARTIFICIAL SALIVA MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 45. AUSTRALIA ARTIFICIAL SALIVA MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 46. CHINA ARTIFICIAL SALIVA MARKET SIZE, BY PRODUCT FORM, 2018-2030 (USD MILLION)
• TABLE 47. CHINA ARTIFICIAL SALIVA MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 48. CHINA ARTIFICIAL SALIVA MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 49. INDIA ARTIFICIAL SALIVA MARKET SIZE, BY PRODUCT FORM, 2018-2030 (USD MILLION)
• TABLE 50. INDIA ARTIFICIAL SALIVA MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 51. INDIA ARTIFICIAL SALIVA MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 52. INDONESIA ARTIFICIAL SALIVA MARKET SIZE, BY PRODUCT FORM, 2018-2030 (USD MILLION)
• TABLE 53. INDONESIA ARTIFICIAL SALIVA MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 54. INDONESIA ARTIFICIAL SALIVA MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 55. JAPAN ARTIFICIAL SALIVA MARKET SIZE, BY PRODUCT FORM, 2018-2030 (USD MILLION)
• TABLE 56. JAPAN ARTIFICIAL SALIVA MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 57. JAPAN ARTIFICIAL SALIVA MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 58. MALAYSIA ARTIFICIAL SALIVA MARKET SIZE, BY PRODUCT FORM, 2018-2030 (USD MILLION)
• TABLE 59. MALAYSIA ARTIFICIAL SALIVA MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 60. MALAYSIA ARTIFICIAL SALIVA MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 61. PHILIPPINES ARTIFICIAL SALIVA MARKET SIZE, BY PRODUCT FORM, 2018-2030 (USD MILLION)
• TABLE 62. PHILIPPINES ARTIFICIAL SALIVA MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 63. PHILIPPINES ARTIFICIAL SALIVA MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 64. SINGAPORE ARTIFICIAL SALIVA MARKET SIZE, BY PRODUCT FORM, 2018-2030 (USD MILLION)
• TABLE 65. SINGAPORE ARTIFICIAL SALIVA MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 66. SINGAPORE ARTIFICIAL SALIVA MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 67. SOUTH KOREA ARTIFICIAL SALIVA MARKET SIZE, BY PRODUCT FORM, 2018-2030 (USD MILLION)
• TABLE 68. SOUTH KOREA ARTIFICIAL SALIVA MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 69. SOUTH KOREA ARTIFICIAL SALIVA MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 70. TAIWAN ARTIFICIAL SALIVA MARKET SIZE, BY PRODUCT FORM, 2018-2030 (USD MILLION)
• TABLE 71. TAIWAN ARTIFICIAL SALIVA MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 72. TAIWAN ARTIFICIAL SALIVA MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 73. THAILAND ARTIFICIAL SALIVA MARKET SIZE, BY PRODUCT FORM, 2018-2030 (USD MILLION)
• TABLE 74. THAILAND ARTIFICIAL SALIVA MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 75. THAILAND ARTIFICIAL SALIVA MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 76. VIETNAM ARTIFICIAL SALIVA MARKET SIZE, BY PRODUCT FORM, 2018-2030 (USD MILLION)
• TABLE 77. VIETNAM ARTIFICIAL SALIVA MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 78. VIETNAM ARTIFICIAL SALIVA MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 79. EUROPE, MIDDLE EAST & AFRICA ARTIFICIAL SALIVA MARKET SIZE, BY PRODUCT FORM, 2018-2030 (USD MILLION)
• TABLE 80. EUROPE, MIDDLE EAST & AFRICA ARTIFICIAL SALIVA MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 81. EUROPE, MIDDLE EAST & AFRICA ARTIFICIAL SALIVA MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 82. EUROPE, MIDDLE EAST & AFRICA ARTIFICIAL SALIVA MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 83. DENMARK ARTIFICIAL SALIVA MARKET SIZE, BY PRODUCT FORM, 2018-2030 (USD MILLION)
• TABLE 84. DENMARK ARTIFICIAL SALIVA MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 85. DENMARK ARTIFICIAL SALIVA MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 86. EGYPT ARTIFICIAL SALIVA MARKET SIZE, BY PRODUCT FORM, 2018-2030 (USD MILLION)
• TABLE 87. EGYPT ARTIFICIAL SALIVA MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 88. EGYPT ARTIFICIAL SALIVA MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 89. FINLAND ARTIFICIAL SALIVA MARKET SIZE, BY PRODUCT FORM, 2018-2030 (USD MILLION)
• TABLE 90. FINLAND ARTIFICIAL SALIVA MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 91. FINLAND ARTIFICIAL SALIVA MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 92. FRANCE ARTIFICIAL SALIVA MARKET SIZE, BY PRODUCT FORM, 2018-2030 (USD MILLION)
• TABLE 93. FRANCE ARTIFICIAL SALIVA MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 94. FRANCE ARTIFICIAL SALIVA MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 95. GERMANY ARTIFICIAL SALIVA MARKET SIZE, BY PRODUCT FORM, 2018-2030 (USD MILLION)
• TABLE 96. GERMANY ARTIFICIAL SALIVA MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 97. GERMANY ARTIFICIAL SALIVA MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 98. ISRAEL ARTIFICIAL SALIVA MARKET SIZE, BY PRODUCT FORM, 2018-2030 (USD MILLION)
• TABLE 99. ISRAEL ARTIFICIAL SALIVA MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 100. ISRAEL ARTIFICIAL SALIVA MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 101. ITALY ARTIFICIAL SALIVA MARKET SIZE, BY PRODUCT FORM, 2018-2030 (USD MILLION)
• TABLE 102. ITALY ARTIFICIAL SALIVA MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 103. ITALY ARTIFICIAL SALIVA MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 104. NETHERLANDS ARTIFICIAL SALIVA MARKET SIZE, BY PRODUCT FORM, 2018-2030 (USD MILLION)
• TABLE 105. NETHERLANDS ARTIFICIAL SALIVA MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 106. NETHERLANDS ARTIFICIAL SALIVA MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 107. NIGERIA ARTIFICIAL SALIVA MARKET SIZE, BY PRODUCT FORM, 2018-2030 (USD MILLION)
• TABLE 108. NIGERIA ARTIFICIAL SALIVA MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 109. NIGERIA ARTIFICIAL SALIVA MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 110. NORWAY ARTIFICIAL SALIVA MARKET SIZE, BY PRODUCT FORM, 2018-2030 (USD MILLION)
• TABLE 111. NORWAY ARTIFICIAL SALIVA MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 112. NORWAY ARTIFICIAL SALIVA MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 113. POLAND ARTIFICIAL SALIVA MARKET SIZE, BY PRODUCT FORM, 2018-2030 (USD MILLION)
• TABLE 114. POLAND ARTIFICIAL SALIVA MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 115. POLAND ARTIFICIAL SALIVA MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 116. QATAR ARTIFICIAL SALIVA MARKET SIZE, BY PRODUCT FORM, 2018-2030 (USD MILLION)
• TABLE 117. QATAR ARTIFICIAL SALIVA MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 118. QATAR ARTIFICIAL SALIVA MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 119. RUSSIA ARTIFICIAL SALIVA MARKET SIZE, BY PRODUCT FORM, 2018-2030 (USD MILLION)
• TABLE 120. RUSSIA ARTIFICIAL SALIVA MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 121. RUSSIA ARTIFICIAL SALIVA MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 122. SAUDI ARABIA ARTIFICIAL SALIVA MARKET SIZE, BY PRODUCT FORM, 2018-2030 (USD MILLION)
• TABLE 123. SAUDI ARABIA ARTIFICIAL SALIVA MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 124. SAUDI ARABIA ARTIFICIAL SALIVA MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 125. SOUTH AFRICA ARTIFICIAL SALIVA MARKET SIZE, BY PRODUCT FORM, 2018-2030 (USD MILLION)
• TABLE 126. SOUTH AFRICA ARTIFICIAL SALIVA MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 127. SOUTH AFRICA ARTIFICIAL SALIVA MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 128. SPAIN ARTIFICIAL SALIVA MARKET SIZE, BY PRODUCT FORM, 2018-2030 (USD MILLION)
• TABLE 129. SPAIN ARTIFICIAL SALIVA MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 130. SPAIN ARTIFICIAL SALIVA MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 131. SWEDEN ARTIFICIAL SALIVA MARKET SIZE, BY PRODUCT FORM, 2018-2030 (USD MILLION)
• TABLE 132. SWEDEN ARTIFICIAL SALIVA MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 133. SWEDEN ARTIFICIAL SALIVA MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 134. SWITZERLAND ARTIFICIAL SALIVA MARKET SIZE, BY PRODUCT FORM, 2018-2030 (USD MILLION)
• TABLE 135. SWITZERLAND ARTIFICIAL SALIVA MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 136. SWITZERLAND ARTIFICIAL SALIVA MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 137. TURKEY ARTIFICIAL SALIVA MARKET SIZE, BY PRODUCT FORM, 2018-2030 (USD MILLION)
• TABLE 138. TURKEY ARTIFICIAL SALIVA MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 139. TURKEY ARTIFICIAL SALIVA MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 140. UNITED ARAB EMIRATES ARTIFICIAL SALIVA MARKET SIZE, BY PRODUCT FORM, 2018-2030 (USD MILLION)
• TABLE 141. UNITED ARAB EMIRATES ARTIFICIAL SALIVA MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 142. UNITED ARAB EMIRATES ARTIFICIAL SALIVA MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 143. UNITED KINGDOM ARTIFICIAL SALIVA MARKET SIZE, BY PRODUCT FORM, 2018-2030 (USD MILLION)
• TABLE 144. UNITED KINGDOM ARTIFICIAL SALIVA MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 145. UNITED KINGDOM ARTIFICIAL SALIVA MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 146. ARTIFICIAL SALIVA MARKET SHARE, BY KEY PLAYER, 2023
• TABLE 147. ARTIFICIAL SALIVA MARKET, FPNV POSITIONING MATRIX, 2023

The Artificial Saliva Market was valued at USD 923.77 million in 2023, expected to reach USD 980.52 million in 2024, and is projected to grow at a CAGR of 6.33%, to USD 1,420.06 million by 2030.

Artificial saliva is a product designed to mimic natural saliva's lubricating functions and is primarily used to treat dry mouth conditions, known as xerostomia. Xerostomia can result from various causes, including medication side effects, radiation therapy, autoimmune diseases, and aging. The necessity of artificial saliva lies in its role in alleviating symptoms associated with dry mouth, which, if untreated, can lead to difficulties in speaking, eating, increased dental decay, and oral infections.

The application scope for artificial saliva is broad, catering mainly to the healthcare industry, specifically in geriatrics, oncology, and for patients under specific pharmacological treatments. Its end-use scope comprises individual patients requiring long-term xerostomia management and healthcare facilities incorporating it into patient care plans. Key growth factors in the artificial saliva market include an aging population, a rise in cancer treatments, and increasing recognition of xerostomia's impact on quality of life. Moreover, an increasing awareness of oral health significantly contributes to market expansion.

Emerging opportunities for this market lie in product innovation, such as developing artificial saliva with added therapeutic benefits or using new formulations that enhance moisture retention. Additionally, identifying and expanding into emerging markets with large elderly populations can offer considerable growth potential. However, challenges in this market include product efficacy concerns, high cost, regulatory approval processes, and competition from alternative treatments like mouthwashes and lozenges.

Areas ripe for innovation and research include developing more effective delivery mechanisms, integrating probiotics and enzymes to mimic natural saliva more closely, and personalized formulations to cater to niche demographics. Overall, the nature of the artificial saliva market is dynamic, characterized by continuous research and development activities striving for better efficacy and patient compliance. For market penetration, companies should focus on educational campaigns to raise awareness about xerostomia and the benefits of artificial saliva products, while maintaining a strong pipeline of innovative, cost-effective solutions to improve user experience.

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Artificial Saliva Market

The Artificial Saliva Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

• Market Drivers
  • Increasing incidences of dry mouth conditions
  • Prevalence of cancer and surge in chemotherapy treatment
  • Rise in dental disorders among individuals worldwide
• Market Restraints
  • Concerns associated with the effectiveness of artificial saliva
• Market Opportunities
  • Innovations in artificial saliva formulations
  • Strategic alliance and collaboration to manufacture artificial saliva
• Market Challenges
  • Complex regulatory approval procedures

Porter's Five Forces: A Strategic Tool for Navigating the Artificial Saliva Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Artificial Saliva Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Artificial Saliva Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Artificial Saliva Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Artificial Saliva Market

A detailed market share analysis in the Artificial Saliva Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Artificial Saliva Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Artificial Saliva Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Artificial Saliva Market

A strategic analysis of the Artificial Saliva Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Artificial Saliva Market, highlighting leading vendors and their innovative profiles. These include Aritech Chemazone Pvt. Ltd., BIO COSMETICS S.L., CCMed Ltd., Forward Science, Fresenius Kabi Ltd., GlaxoSmithKline PLC, ICPA Health Products Ltd., Kuraray Europe GmbH, LIVEALTH BIOPHARMA (UK) PVT. LTD., Merck KGaA, NANOCHEMAZONE, Parnell Pharmaceuticals, Inc., Pickering Laboratories, Inc., and Saliwell Ltd..

Market Segmentation & Coverage

This research report categorizes the Artificial Saliva Market to forecast the revenues and analyze trends in each of the following sub-markets:

• Based on Product Form, market is studied across Gel, Liquid, Powder, Spray, and Tablets.
• Based on End-User, market is studied across Adult and Pediatric.
• Based on Distribution Channel, market is studied across Offline and Online.
• Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

• 1.1. Objectives of the Study
• 1.2. Market Segmentation & Coverage
• 1.3. Years Considered for the Study
• 1.4. Currency & Pricing
• 1.5. Language
• 1.6. Stakeholders

2. Research Methodology

• 2.1. Define: Research Objective
• 2.2. Determine: Research Design
• 2.3. Prepare: Research Instrument
• 2.4. Collect: Data Source
• 2.5. Analyze: Data Interpretation
• 2.6. Formulate: Data Verification
• 2.7. Publish: Research Report
• 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

• 5.1. Market Dynamics
  • 5.1.1. Drivers
    • 5.1.1.1. Increasing incidences of dry mouth conditions
    • 5.1.1.2. Prevalence of cancer and surge in chemotherapy treatment
    • 5.1.1.3. Rise in dental disorders among individuals worldwide
  • 5.1.2. Restraints
    • 5.1.2.1. Concerns associated with the effectiveness of artificial saliva
  • 5.1.3. Opportunities
    • 5.1.3.1. Innovations in artificial saliva formulations
    • 5.1.3.2. Strategic alliance and collaboration to manufacture artificial saliva
  • 5.1.4. Challenges
    • 5.1.4.1. Complex regulatory approval procedures
• 5.2. Market Segmentation Analysis
• 5.3. Porter's Five Forces Analysis
  • 5.3.1. Threat of New Entrants
  • 5.3.2. Threat of Substitutes
  • 5.3.3. Bargaining Power of Customers
  • 5.3.4. Bargaining Power of Suppliers
  • 5.3.5. Industry Rivalry
• 5.4. PESTLE Analysis
  • 5.4.1. Political
  • 5.4.2. Economic
  • 5.4.3. Social
  • 5.4.4. Technological
  • 5.4.5. Legal
  • 5.4.6. Environmental

6. Artificial Saliva Market, by Product Form

• 6.1. Introduction
• 6.2. Gel
• 6.3. Liquid
• 6.4. Powder
• 6.5. Spray
• 6.6. Tablets

7. Artificial Saliva Market, by End-User

• 7.1. Introduction
• 7.2. Adult
• 7.3. Pediatric

8. Artificial Saliva Market, by Distribution Channel

• 8.1. Introduction
• 8.2. Offline
• 8.3. Online

9. Americas Artificial Saliva Market

• 9.1. Introduction
• 9.2. Argentina
• 9.3. Brazil
• 9.4. Canada
• 9.5. Mexico
• 9.6. United States

10. Asia-Pacific Artificial Saliva Market

• 10.1. Introduction
• 10.2. Australia
• 10.3. China
• 10.4. India
• 10.5. Indonesia
• 10.6. Japan
• 10.7. Malaysia
• 10.8. Philippines
• 10.9. Singapore
• 10.10. South Korea
• 10.11. Taiwan
• 10.12. Thailand
• 10.13. Vietnam

11. Europe, Middle East & Africa Artificial Saliva Market

• 11.1. Introduction
• 11.2. Denmark
• 11.3. Egypt
• 11.4. Finland
• 11.5. France
• 11.6. Germany
• 11.7. Israel
• 11.8. Italy
• 11.9. Netherlands
• 11.10. Nigeria
• 11.11. Norway
• 11.12. Poland
• 11.13. Qatar
• 11.14. Russia
• 11.15. Saudi Arabia
• 11.16. South Africa
• 11.17. Spain
• 11.18. Sweden
• 11.19. Switzerland
• 11.20. Turkey
• 11.21. United Arab Emirates
• 11.22. United Kingdom

12. Competitive Landscape

• 12.1. Market Share Analysis, 2023
• 12.2. FPNV Positioning Matrix, 2023
• 12.3. Competitive Scenario Analysis
• 12.4. Strategy Analysis & Recommendation

Companies Mentioned

• 1. Aritech Chemazone Pvt. Ltd.
• 2. BIO COSMETICS S.L.
• 3. CCMed Ltd.
• 4. Forward Science
• 5. Fresenius Kabi Ltd.
• 6. GlaxoSmithKline PLC
• 7. ICPA Health Products Ltd.
• 8. Kuraray Europe GmbH
• 9. LIVEALTH BIOPHARMA (UK) PVT. LTD.
• 10. Merck KGaA
• 11. NANOCHEMAZONE
• 12. Parnell Pharmaceuticals, Inc.
• 13. Pickering Laboratories, Inc.
• 14. Saliwell Ltd.